Clinical trial
Sildenafil for Improving Outcomes After Valvular Correction
NCT00862043 is registered in ClinicalTrials.gov with Hospital General Universitario Gregorio Marañon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sildenafil for Improving Outcomes After Valvular Correction
- Lead sponsor
- Hospital General Universitario Gregorio Marañon
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- July 31, 2016
- Enrollment
- 200 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
pulmonary hypertension, valvular heart disease